New insights into early intervention of chronic obstructive pulmonary disease with mild airflow limitation

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015; 5(2): 020415. doi:10.7189/jogh.05.02041526755942
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11): e442. doi:10.1371/journal.pmed.003044217132052
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009; 64(10): 863–868. doi:10.1136/thx.2009.11572519553233
   PubMed Web of Science ®Google Scholar
• Lundback BLA, Lindstrom M, Ronmark E, et al. Not 15 but 50% of smokers develop COPD?–report from the obstructive lung didease in Northern Sweden studies. Respir Med. 2003; 97(2). doi:10.1053/rmed.2003.1446
   Web of Science ®Google Scholar
• Bednarek MMJ, Wozniak M, Kuca P, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008; 63(5). 402–407 doi:10.1136/thx.2007.08545618234906
   PubMed Web of Science ®Google Scholar
• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007; 176(8): 753–760. doi:10.1164/rccm.200612-1749OC17575095
   PubMed Web of Science ®Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589): 741–750. doi:10.1016/S0140-6736(07)61377-417765523
   PubMed Web of Science ®Google Scholar
• Mapel DW, Dalal AA, Blanchette CM, et al. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chronic Obstr. 2011; 6: 573–581.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology. 2017; 22(3): 575–601. doi:10.1111/resp.1301228150362
   PubMed Web of Science ®Google Scholar
• Karrasch S, Bruske I, Smith MP, et al. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study. Int J Chronic Obstr. 2016; 11: 1881–1894. doi:10.2147/COPD.S104529
   Web of Science ®Google Scholar
• Guder G, Brenner S, Angermann CE, et al. “GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study“. Respir Res. 2012; 13(1): 13. doi:10.1186/1465-9921-13-1322309369
   PubMed Web of Science ®Google Scholar
• Hogg JC, Macklem PT, Thurlbeck WM Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968; 278(25): 1355–1360. doi:10.1056/NEJM1968062027825015650164
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350(26): 2645–2653. doi:10.1056/NEJMoa03215815215480
   PubMed Web of Science ®Google Scholar
• Deesomchok A, Webb KA, Forkert L, et al. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. Copd. 2010; 7(6): 428–437. doi:10.3109/15412555.2010.52808721166631
   PubMedGoogle Scholar
• Elbehairy AF, Ciavaglia CE, Webb KA, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. 2015; 191(12): 1384–1394. doi:10.1164/rccm.201501-0157OC25826478
   PubMed Web of Science ®Google Scholar
• Guenette JA, Chin RC, Cheng S, et al. Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur Respir J. 2014; 44(5): 1177–1187. doi:10.1183/09031936.0003471425142487
   PubMed Web of Science ®Google Scholar
• Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 177(6): 622–629. doi:10.1164/rccm.200707-1064OC18006885
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985). 2009; 106(6): 1902–1908. doi:10.1152/japplphysiol.00085.200919372303
   PubMed Web of Science ®Google Scholar
• Peinado VI, Pizarro S, Barbera JA Pulmonary vascular involvement in COPD. Chest. 2008; 134(4): 808–814. doi:10.1378/chest.08-082018842913
   PubMed Web of Science ®Google Scholar
• Hueper K, Vogel-Claussen J, Parikh MA, et al. Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD Study. Am J Respir Crit Care Med. 2015; 192(5): 570–580. doi:10.1164/rccm.201411-2120OC26067761
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5): 1256–1276. doi:10.1164/ajrccm.163.5.210103911316667
   PubMedGoogle Scholar
• Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015; 175(9): 1539–1549. doi:10.1001/jamainternmed.2015.273526098755
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R The natural history of chronic airflow obstruction. Br Med J. 1977; 1(6077): 1645–1648.871704
   PubMed Web of Science ®Google Scholar
• Tantucci C, Modina D Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012; 7: 95–99. doi:10.2147/COPD.S2748022371650
   PubMed Web of Science ®Google Scholar
• Jenkins CR, Jones PW, Calverley PMA, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Resp Res. 2009; 10:59.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011; 365(13): 1184–1192. doi:10.1056/NEJMoa110548221991892
   PubMed Web of Science ®Google Scholar
• Bhatt SP, Soler X, Wang X, et al. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Resp Crit Care. 2016; 194(2): 178–184. doi:10.1164/rccm.201511-2219OC
   PubMed Web of Science ®Google Scholar
• Lange P, Celli B, Agusti A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. New Engl J Med. 2015; 373(2): 111–122. doi:10.1056/NEJMoa141153226154786
   PubMed Web of Science ®Google Scholar
• Schroeder JD, McKenzie AS, Zach JA, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. Am J Roentgenol. 2013; 201(3): W460–W470. doi:10.2214/AJR.12.1010223971478
   PubMed Web of Science ®Google Scholar
• McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. New Engl J Med. 2011; 365(17): 1567–1575. doi:10.1056/NEJMoa110695522029978
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Resp Res. 2010; 11:122.
   PubMed Web of Science ®Google Scholar
• Steuten LMCE, Vrijhoef HJ, Wouters EF COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 2006; 15(2). doi:10.1016/j.pcrj.2005.09.001
   Google Scholar
• Guenette JA, Jensen D, Webb KA, et al. Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respir Physiol Neurobiol. 2011; 177(3): 218–227. doi:10.1016/j.resp.2011.04.01121524719
   PubMed Web of Science ®Google Scholar
• O‘Donnell DE, Laveneziana P, Webb K, et al. Chronic obstructive pulmonary disease: clinical integrative physiology. Clin Chest Med. 2014; 35(1):51. doi:10.1016/j.ccm.2013.09.00824507837
   PubMed Web of Science ®Google Scholar
• Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012; 40(5): 1115–1122. doi:10.1183/09031936.0017011122362854
   PubMed Web of Science ®Google Scholar
• Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010; 36(1): 81–88. doi:10.1183/09031936.0010490919897554
   PubMed Web of Science ®Google Scholar
• Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008; 63(9): 768–774. doi:10.1136/thx.2007.09372418505800
   PubMed Web of Science ®Google Scholar
• O‘Reilly JF, Williams AE, Holt K, et al. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J. 2006; 15(6): 346–353. doi:10.1016/j.pcrj.2006.08.00917064963
   PubMedGoogle Scholar
• Langsetmo L, Platt RW, Ernst P, et al. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008; 177(4): 396–401. doi:10.1164/rccm.200708-1290OC18048806
   PubMed Web of Science ®Google Scholar
• Decramer M, Rennard S, Troosters T, et al. COPD as a lung disease with systemic consequences - clinical impact, mechanisms, and potential for early intervention. Copd-J Chron Obstruct Pulmon Dis. 2008; 5(4): 235–256. doi:10.1080/15412550802237531
   Web of Science ®Google Scholar
• de Torres JP, Marin JM, Casanova C, et al. Lung cancer in patients with chronic obstructive pulmonary disease incidence and predicting factors. Am J Resp Crit Care. 2011; 184(8): 913–919. doi:10.1164/rccm.201103-0430OC
   PubMed Web of Science ®Google Scholar
• Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med. 2009; 122(8). 778.e9–778.e15 doi:10.1016/j.amjmed.2009.01.036
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Murray RP Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002; 166(5): 675–679. doi:10.1164/rccm.211209612204864
   PubMed Web of Science ®Google Scholar
• Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000; 161(2 Pt 1): 381–390. doi:10.1164/ajrccm.161.2.990104410673175
   PubMed Web of Science ®Google Scholar
• Corhay JL, Dang DN, Van Cauwenberge H, et al. Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy. Int J Chron Obstruct Pulmon Dis. 2014; 9: 27–39. doi:10.2147/COPD.S5201224368884
   PubMed Web of Science ®Google Scholar
• Jacome C, Marques A Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care. 2014; 59(4): 588–594. doi:10.4187/respcare.0274224106321
   PubMed Web of Science ®Google Scholar
• Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009; 374(9696): 1171–1178. doi:10.1016/S0140-6736(09)61298-819716598
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhong NS, Li X, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017; 377(10): 923–935. doi:10.1056/NEJMoa170022828877027
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Lange P Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996; 153(5): 1530–1535. doi:10.1164/ajrccm.153.5.86305978630597
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Resp Crit Care. 2017; 195(3): 324–330.
   PubMed Web of Science ®Google Scholar
• Harvey BG, Strulovici-Barel Y, Kaner RJ, et al. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity. Eur Respir J. 2015; 46(6): 1589–1597. doi:10.1183/13993003.02377-201426541521
   PubMed Web of Science ®Google Scholar
• Yuan R, Hogg JC, Pare PD, et al. Prediction of the rate of decline in FEV1 in smokers using quantitative computed tomography. Thorax. 2009; 64(11): 944–949. doi:10.1136/thx.2008.11243319734130
   PubMed Web of Science ®Google Scholar
• Park HY, Churg A, Wright JL, et al. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 188(12): 1413–1419. doi:10.1164/rccm.201305-0892OC24245748
   PubMed Web of Science ®Google Scholar
• Leung JM, Mayo J, Tan W, et al. the Pan-Canadian Early Lung Cancer Study Group. Plasma pro-surfactant protein B and lung function decline in smokers. Eur Respir J. 2015; 45: 1037–1045.56. doi:10.1183/09031936.0018421425614175
   PubMed Web of Science ®Google Scholar
• Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J. 2011; 37(3): 516–522 doi:10.1183/09031936.0002931020595148
   PubMed Web of Science ®Google Scholar
• Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010; 42(1): 45–52. doi:10.1038/ng.50020010835
   PubMed Web of Science ®Google Scholar